← Back
Data updated: Mar 10, 2026
AURINIA
ImmunologyOphthalmology
AURINIA is a pharmaceutical company focused on Immunology, Ophthalmology. Key products include LUPKYNIS.
2021
Since
1
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 86%
1 drugs Phase 3: 4 Phase 2: 1
Ophthalmology 14%
0 drugs Phase 2: 2
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-01-22
- Latest
- 2025-10-08
- Applications
- 1